| Literature DB >> 31888236 |
Roxana Cristina Popescu1,2, Ecaterina Andronescu1, Bogdan Stefan Vasile1.
Abstract
Functionalization of nanomaterials can enhance and modulate their properties and behaviour, enabling characteristics suitable for medical applications. Magnetite (Fe3O4) nanoparticles are one of the most popular types of nanomaterials used in this field, and many technologies being already translated in clinical practice. This article makes a summary of the surface modification and functionalization approaches presented lately in the scientific literature for improving or modulating magnetite nanoparticles for their applications in nanomedicine.Entities:
Keywords: Fe3O4; biocompatibility; clinical translation; conjugation; functionalization; magnetite nanoparticles; nanomedicine; surface modification
Year: 2019 PMID: 31888236 PMCID: PMC6956201 DOI: 10.3390/nano9121791
Source DB: PubMed Journal: Nanomaterials (Basel) ISSN: 2079-4991 Impact factor: 5.076
Influence of reaction parameters on the properties of magnetite nanoparticles resulting from the co-precipitation method.
| No. | Reaction Parameter | Property | Measure | Reference |
|---|---|---|---|---|
| 1 | Fe3+/Fe2+ ratio | Iron oxide phase | Directly proportional | [ |
| Magnetism | Inversely proportional | [ | ||
| Dimension | Directly proportional | [ | ||
| 2 | pH value | Iron oxide phase | Inversely proportional | [ |
| Magnetism | Inversely proportional | [ | ||
| Dimension | Insignificant | [ | ||
| 3 | Type of base | Iron oxide phase | Depending on the type of base | [ |
| Magnetism | Depending on the type of base | [ | ||
| Dimension | Depending on the type of base | [ | ||
| 4 | Temperature | Iron oxide phase | Directly proportional | [ |
| Magnetism | Inversely proportional | [ | ||
| Dimension | Inversely proportional | [ | ||
| 5 | Concentration of precursors | Dimension | Directly proportional | [ |
| 6 | pH of the precursor solution | Iron oxide phase | [ | |
| Magnetism | [ | |||
| Dimension | Directly proportional | [ | ||
| 7 | Addition of surfactants | Dimension | Directly proportional | [ |
| Surface charge | Dependent on the surfactant | [ | ||
| Composition | Dependent on the surfactant | [ | ||
| Shape | Dependent on the surfactant | [ | ||
| Magnetisation | Dependent of the surfactant | [ |
Figure 1Schematic representation of the two main types of magnetite nanoparticle functionalization processes for medical applications: in situ, respectively, post-synthesis functionalization.
Recent approaches in Fe3O4-SiO2 based nanostructures conjugates.
| No. | System Description | Application | Type of Conjugation | Evaluation | Reference |
|---|---|---|---|---|---|
| 1 | Fe3O4@SiO2 | Magnetic resonance imaging contrast substance as in vivo stem cell tracker | Negatively charged Fe3O4@citrate act as seeds for Si precursor; encapsulation using sol gel method; | Determination of distribution and chemical changes dynamics of Fe3O4@SiO2; high chemical stability; distribution in cytoplasm; | [ |
| 2 | Fe3O4@SiO2/anti-rHBsAg (Hepatitis B surface antigen) | Purification of recombinant Hepatitis B for vaccine production; | In situ functionalization; encapsulation using sol gel method; | In vitro isolation of rHBsAg antigen from Pichia pastoris yeast | [ |
| 3 | Fe3O4@SiO2 | Plasmid DNA purification | SiCl4 cross-linker between Fe3O4@NH3 and (3-aminopropyl)triethoxysilane (APTES); encapsulation using sol gel method; | Efficient in vitro plasmid DNA purification from | [ |
| 4 | Fe3O4@boronic acid/mesoporous (m) SiO2 | Magnetic and pH triggered drug release; | − | Biocompatibility and high uptake in MC3T3-E1 cells; | [ |
| 5 | Fe3O4@mSiO2/catalase (CAT) | Enzyme protection in catalysis; | Encapsulation in SiO2 using TMOS (tetramethoxysilane) functionalization with APTES for CAT conjugation and growth of mSiO2 using CTAB as template and TMOS; | Good stability and catalytic activity | [ |
| 6 | Fe3O4@oleic acid@mSiO2/5-Fluorouracil | Drug delivery for cancer therapy; | In situ Fe3O4@oleic acid were functionalized with CTAB through weak interaction (Van der Waals); hydrolisation of tetraethoxysilane (TEOS) on Fe3O4/CTAB; encapsulation in mSiO2 using the inversed microemulsion method; | In vitro biocompatibility for MCF-7 cells; efficient drug loading; | [ |
Figure 2Star-shaped gold-conjugated Fe3O4 nanoparticles; functionalization with organic molecules (polyethyleneimine, PEI): (a) schematic representation of the synthesis and conjugation processes; (b) ultraviolet–visible (UV–VIS) spectra for (non-) irradiated the nano-constructs; (c) transmission electron micrograph (TEM) of the resulted nanoconstructs; (d) histogram distribution of size; (e) high-resolution TEM (HR-TEM) of the resulted nanoconstructs; reprinted from [137].
Recent approaches in Fe3O4-carbon-based nanostructures conjugates.
| No. | System Description | Application | Type of Conjugation | Evaluation | Reference |
|---|---|---|---|---|---|
| 1. | Fe3O4 @APS–graphene/5-Fluorouracil | Drug-delivery systems for cancer treatment; | Amide bonding using 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide | In vitro drug release at acidic pH; efficient in vitro internalizing in hepatocarcinoma HepG2 cells; biocompatibility of the carrier nanoparticles; | [ |
| 2. | Fe3O4@ APTES/graphene oxide (GO)/doxorubicin | Drug-delivery systems and imaging diagnosis in cancer management; | Amide bonding using N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC) | In vitro low cytotoxicity compared to GO; superparamegnetic properties and 10.7 r2/r1 relaxivity; fluorescence in VIS; high doxorubicin loading and 2.5 fold higher efficiency; ( | [ |
| 3. | Fe3O4@azide-sodium ascorbate-GO@ alkyne | Efficient absorbent and removal of dyes; | Click chemistry approach between the azide functional groups on the Fe3O4, sodium L-ascorbate and alkyne functional groups on GO; | Superparamagnetic properties; efficient absorbent and removal of dyes; | [ |
| 4. | Fe3O4@GO | Magnetic fluids; | Absorption; | Improvement of friction and wear performances with magnetic field; | [ |
| 5. | Polyvinyl alcohol (PVA)/ Fe3O4@ carbon nanotubes (CNTs) | Absorbent and dye removal; Anti-bacterial effects; | − | Optimal dye removal and anti-bacterial properties; | [ |
| 6. | Fe3O4/multi walled CNTs/laser scribed graphene/chitosan/glassy carbon electrode | Detection of heavy metals | − | Electrode for the determination of Cd2+ and Pb2+ using square wave anodic stripping voltammetry; wide linear range; ultralow detection limit; excellent repeatability, reproducibility, stability; | [ |
| 7. | Single-walled CNTs-PEG-Fe3O4@ carbon quantum dots (CQD)/doxorubicin/sgc8c aptamer | Targeted photodynamic and photothermal ablation of tumor cells; controlled drug delivery; targeted imaging using fluorescence and magnetic resonance imaging (MRI) | Through polyethylene glycol (PEG) linker using amide bonding; | Near infrared triggered production of reactive oxygen species and heat; good imaging properties; good biocompatibility of the carrier and cellular internalization; high drug loading ability; selective accumulation at tumor site in human adenocarcinoma (HeLa) tumor-bearing mice intravenously injected with the system; | [ |
| 8. | GO-Chitosan/Fe3O4/glucose oxidase | Glucose biosensor and magnetic resonance imaging; | − | Good glucose biosensing ability; | [ |
Figure 4Surface conjugation of magnetite nanoparticles with oleic acid: transmission electron microscopy (TEM) image for (a) bare Fe3O4, respectively (b) oleic acid conjugated Fe3O4; particle diameter distribution for (c) bare Fe3O4, respectively (d) oleic acid conjugated Fe3O4; (e) schematic representation of the capping principle; (f) Fourier transform infrared (FTIR) spectra of Fe3O4 (1) Fe3O4/oleic acid (2), respectively oleic acid (3); (g) thermogravimetric analysis (TGA) and differential thermogravimetric analysis (DTA) curves for oleic acid conjugated Fe3O4; adapted from [219].
Recent approaches in Fe3O4-polymer-based nanostructures conjugates.
| No. | System Description | Application | Type of Conjugation | Evaluation | Reference |
|---|---|---|---|---|---|
| 1. | Fe3O4@ poly(polyethylene glycol methacrylate-co-acrylic acid) (P(PEGMA-AA)) | Hyperthermia and MRI contrast substance; | Electrostatic interactions between the acrylic acid and positively-charged Fe3O4; | Improved stability and salt tolerance; excellent blood compatibility; formation of blood protein corona; resistance to cell internalization; improvement of contrast in MRI; | [ |
| 2. | Fe3O4/methyl methacrylate/ethylene glycol dimethacrylate/hydroxyl ethyl methacrylate/gemcitabine | Hyperthermia and drug delivery for cancer therapy | − | Good incorporation of drug; temperature triggered release; ( | [ |
| 3. | Fe3O4@PEG/Doxorubicin | Drug delivery and hyperthermia in cancer treatment; | In situ conjugation | pH responsive release of drug; no cytotoxicity of Fe3O4@PEG for human fibroblasts; Fe3O4@PEG/Doxorubicin showed good internalization and cytotoxicity for mouse skin fibrosarcoma; good magnetic properties; | [ |
| 4. | Fe3O4@ poly(lactic-co-glycolicacid) (PLGA)-PEG@ folic acid/curcumin | Targeted drug delivery for cancer treatment; | Encapsulation; | High drug loading and delivery; high in vitro targeting efficiency for cervical carcinoma; in vitro induction of apoptosis and reduction of tumor cell proliferation; | [ |
| 5. | Fe3O4@ C/carboxymethyl cellulose/chitosan/diclofenac sodium | Controlled drug delivery; | In situ conjugation and subsequent electrostatic conjugation; | High drug-loading efficiency; pH sensitive drug delivery; | [ |
| 6. | Fe3O4@ dextran | − | Covalent binding via electron pairing; | − | [ |
| 7. | Fe3O4@dextran | Near-infrared (NIR) photothermal ablation of tumor cells; | In situ encapsulation; | In vitro biocompatibility; in vitro and in vivo tumor growth inhibition after NIR activation; | [ |
| 8. | Fe3O4@ poly ε acrylic acid-gelatin/hydroxyapatite/polycaprolactone | Bone tissue engineering scaffolds for hyperthermia cancer treatment; | Electrostatic interactions between the acrylic acid and positively-charged Fe3O4; | Characterisation of the magnetic behaviour for hyperthermia applications; | [ |
| 9. | Fe3O4/poly-L-lactide (PLLA) nanofibers | Bone tissue engineering; | − | In vivo evaluation on tibia defect rabbit model; computer tomography and histological investigations revealed higher bone-healing potential than conventional PLLA | [ |
Figure 6Matrix-assisted pulsed laser evaporation (MAPLE)-deposited Fe3O4@Cinnamomum verum at fluence F = 400 mJ/cm2: Infrared microscopy-distribution of intensity of (a) 2815 cm−1, (b) 1689 cm−1, (c) IR spectra; (d) biocompatibility evaluation for endothelial cells; antibacterial evaluation—S. aureus biofilm formation (e), respectively, E. coli biofilm formation (f) [32].